That is very important, since the method a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work. In other words, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (jeff brown investor prediction). Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're developed to do. This was an advancement nearly no one saw. But it's going to have profound ramifications for treating illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be lots of investment chances in this area, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown genetic sequencer stock). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it pulled back possibly substantially prior to going higher - jeff brown 2021 predictions. I have actually been covering bitcoin for a long time now. One of the first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mostly educating readers. But that's not the big concern any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a relied on 170-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. jeff brown 1 biotech. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are numerous fantastic private companies on the edge of striking the general public markets And I have actually been working on a new method for you to invest even prior to these companies go public.
This opportunity has actually been developing over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the information. Go right here to reserve your area free of charge.
Emma Walsh here, managing editor of the Diary. Routine Journal readers know that tech isn't our usual beat (jeff brown 1 biotech). And when it comes to tech investing, we leave it to the professionals. The good news is, we have a number of such specialists in our Rolodex. Our coworker Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing professionals we know (black sea). In truth, he had numerous triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and anticipate what's just around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and far more. These patterns are experiencing exponential growth and developing extraordinary opportunities for investors. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. melania trump. But in spite of what lots of readers might think, this is a pattern that's simply getting going. Although the COVID-19 pandemic disrupted supply chains last year, an outstanding 250 million 5G-enabled devices were still offered.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (artificial intelligence). Losing 2 months of manufacturing and sales actually impacts the number of 5G gadgets are sold in the calendar year. When you think about all of that, offering 250 million systems is impressive. More notably, the hold-ups brought on by the pandemic produced a lots of bottled-up demand. And that demand is now going to be pushed into 2021. In reality, I predict that more than 500 million 5G devices will be delivered in 2021 - social media. And that's not my only 5G prediction When I have actually discussed 5G in the past, I have actually described its 3 various phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Phase 3, 5G services begin to be used (first lady). That's when we start to see applications operating on 5G networks. Consider things like huge multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Stage 3 by this summertime. This starts something of a virtuous cycle: Many people do not really care about the innovation. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That results in more 5G apps being developed. In truth, 5G is going to open up a suite of unbelievable applications: self-driving cars and trucks, the Web of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment opportunities moving forward will be massive. Stepping away from 5G, the next important innovation I foresee in 2021 is CRISPR hereditary editing. CRISPR stands for "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it is among the most exciting developments in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software application.
The program can crash or not function properly. CRISPR utilizes a comparable idea but with our hereditary code. "Typos" in our genome can result in illness. CRISPR can remedy these "typos." For several years, CRISPR was mainly a specific niche innovation that wasn't well understood. And throughout that time, there were really only 3 companies operating in this space. But things are altering. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this technology just works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and delivering incredible returns. This entire market is effectively a greenfield chance.
There's room for lots of companies to exist in this space. jeff brown market predictions. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or three more genetic editing companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things happening at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software application can properly forecast the folding of a protein based solely on its amino acid sequence with 92. 4% precision. That's crucial because the way a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been an experimental process. But now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're created to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however several drug therapies produced utilizing this innovation. This was one of those breakthroughs that practically nobody noticed. But it's going to have profound ramifications for curing illness. And, of course, there will be plenty of financial investment chances in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it drew back maybe substantially before going higher. I have actually been covering bitcoin for a long period of time now. Among the very first research reports I ever released was on bitcoin - future report review. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. However at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
However no one is asking that question any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. genetic sequencer stock jeff brown. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the details depends on date as of February 2021, however we could not independently validate this claim. Given Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down an accurate figure at this minute. Brown is best understood for his sage-like capability to select winning technology stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an excellent perspective on the market. He's always on the hunt for brand-new chances, and he shares a number of his best picks in the Near Future Report.
That's high praise, however it's not absurdly reasoned. Brown has an outstanding credibility as a stock-picker, and he successfully predicted a few of the biggest economic occasions of the previous 20 years. Although he does not appear to launch his picks to the public, the service's success is a direct indicator of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal every time, but Jeff Brown's accurate predictions have actually earned him legions of devoted fans. That states a lot about his ability. The Near Future Report is published by Brownstone Research, a prominent financial research study publisher. Brownstone Research uses a number of research services with a wide array of specializations - jeff brown latest prediction.
The company is likewise affiliated with Bonner & Partners, another well-respected research publisher - jeff brown genome sequencing stock. On its website, Brownstone says its objective is to supply retail financiers with professional-grade research: "For too long, the very best financial investment research has not been offered to private financiers. It has been normally reserved for investment banks, hedge funds, private equity, and high-net-worth clients. second wave. The mission of Brownstone Research is to make that type of proprietary research readily available to any investors seeking to gain an edge in the marketplaces. The objective is basic to deliver distinct and lucrative investment research discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise works as the company's Chief Investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After years of steady success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a household name throughout the majority of America. If you know even a little bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. diplomatic relations. Whatever he touches turns to gold! Jeff is well aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In fact, Brown believes S.A.V. korean actress. could be "the biggest pattern of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be weding two innovative technologies: expert system and electrical automobiles. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving vehicles ever. It's nothing brief of the automobile industry's Holy Grail. As you understand, electrical vehicles and self-driving car stocks have been huge this year, but the Wall Street machine has actually been huge on hype without much concrete outcome. Regardless of an extreme increase in competition over the previous couple of years, Brown still believes Musk has the finest chance of putting all of it together.
tech could be the magic string that ties it all together. S.A.V. means Shared Autonomous Lorry, and it could be the future of transport. Basically, this innovation would allow you to lease your vehicle as an autonomous, self-driving taxi when you're not utilizing it. You just leave the automobile and press a button on an app that tells the automobile to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your automobile shuttles ride-sharers around town. Best of all, you get to keep a significant portion of the profits. It sounds insane, however it might be closed than you believe.